Mirugen Secures Investment to Commercialise ResearchCharlotte Casebourne StockDec 23, 20241 min readUpdated: Aug 4https://www.health.gov.au/ministers/the-hon-mark-butler-mp/media/185-million-to-commercialise-research-to-cure-blindness-find-cancer-and-make-childbirth-safer
Mirugen Secures A$4.5m to Pioneer Cell (Re)programming, and Welcomes Charlotte Casebourne Stock as Executive Chair
